Navigation Links
Today on Capitol Hill: The Malaria Forum
Date:4/21/2009

- Interdisciplinary team of experts joins forces to discuss the latest tools to combat this preventable but deadly disease -

BRIDGEWATER, N.J., April 21 /PRNewswire/ -- Today on Capitol Hill Congressmen Don Payne and John Boozman, co-chairs of the Congressional Malaria Caucus, join global pharmaceutical company sanofi-aventis and the non-profit Drugs for Neglected Disease initiative (DNDi) to host the Malaria Forum. The Malaria Forum offers an important opportunity to gain insights on health initiatives and partnerships that are focused on combating this dreaded disease worldwide.

Every year, as many as one million people die from malaria and another 300-500 million suffer from it. Malaria remains the leading cause of death for children under the age of five in Africa, and kills one child every 30 seconds worldwide.

The sanofi-aventis group has been present in Africa for decades and extensively in countries affected by malaria. In 2001, the Impact Malaria initiative, the first program from the sanofi-aventis Access to Medicines team was created mobilizing the company's expertise and resources to fight diseases including malaria.

DNDi, an independent, non-profit pharmaceutical research and development (R&D) organization, has been involved in developing and making available needs-adapted treatments for a group of deadly neglected diseases traditionally ignored by market-driven mechanisms for drug development. Since its founding in 2003, DNDi has already developed and made available two antimalarial medicines while reaching out in partnership to those in the remotest areas in Africa as well as the largest pharmaceutical companies in the world.

Dr. Francois Bompart, who is part of the sanofi-aventis group's Access to Medicine team, will discuss the importance of educating communities, healthcare professionals and families about malaria and adapting medicines to meet patient needs. "Our mission is to bring together all of sanofi-aventis' expertise in order to provide patients in developing countries with access to medicines and vaccines for specific diseases, such as malaria. However, based on the knowledge that medicines alone cannot solve all problems we are also involved in education, information and prevention initiatives in these countries. We are deeply committed to our continued efforts in promoting better health for patients worldwide and to satisfy unmet healthcare needs."

Hellen Gelband, a malaria expert and member of the Board of Directors of DNDi North America, will discuss the impact and needs of patients with neglected diseases like malaria, with a focus on how the medicine, ASAQ (artesunate-amodiaquine)(1) was developed in partnership with sanofi-aventis. In addition, Ms. Gelband will discuss why various types of partners, from the public and private sectors, are critical in addressing the global health imbalance and how DNDi is utilizing a wide array of partnerships in its patient-driven drug development model, which is already delivering concrete benefits to patients in the form of two new malaria drugs in use in the field.

The Malaria Forum will take place on Tuesday, April 21 from 3:00 PM - 4:30 PM at 2200 Rayburn House Office Building. It is not open to the public.

(1) ASAQ is not approved in the U.S.

About sanofi-aventis

Sanofi-aventis is a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients and their families. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi-aventis U.S. is a U.S. affiliate of sanofi-aventis. For more information, visit www.sanofi-aventis.us or www.sanofi-aventis.com

US.COR.09.04.024

    Contact:
    Elizabeth Baxter - sanofi-aventis, +1-908-981-5360
    elizabeth.baxter@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Good News for Tough Times: Small, Private University Responds to Todays Economic Challenges
2. City of Warrensville Heights Residents Have Access to Easy-to-Use Prescription Drug Discount Card Launched Today
3. TopBestPennyStocks.com Issues Technical Trade Alerts on Hot Stocks in the Market Today: CAST, VM, NFLX, PFE, AA, & COF
4. National Physicians Study: Nearly One Third Would Choose Different Career Today
5. Americas Egg Farmers to Participate in Annual White House Easter Egg Roll Today
6. Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinsons Disease
7. MedPage Today Pledges to Maintain and Expand News Coverage in 2009
8. Mayer Labs Acquires Today(R) Sponge Distribution Rights
9. National Public Health Week Begins Today With Launch of Viral Video Campaign
10. Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines
11. Smokers Have Greater Incentive to Quit, as Big Tobacco Tax Hike Goes Into Effect Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... The old expression “a ... problem. A common injury that’s often misunderstood, whiplash should be swiftly diagnosed and treated ... orthopedic spine surgeon at Atlantic Spine Center . , So named because ...
(Date:5/24/2016)... ... 24, 2016 , ... Researchers from Catholic Health Initiatives (CHI) ... bleeding complications from percutaneous coronary intervention (PCI). The data, presented at the annual ... document a 40% reduction in risk-adjusted bleeding event rates over a two-year period ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... web-based software module. The cutting-edge feature provides end users with an embedded, ... self-service business intelligence solution and its analytics engine. , This powerful ...
(Date:5/23/2016)... Akron, Ohio (PRWEB) , ... May 23, 2016 ... ... not-for-profit continuing care retirement community, dedicated its new $11.5 million, 64-room assisted living ... an invitation-only ceremony and ribbon cutting. , The new building provides the ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an article ... than 1% of United Kingdom residents who could benefit from bariatric surgery are actually ... increases the number of bariatric procedures it offers to obese patients from 6,000 to ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... 19, 2016 A new report ... Market -Opportunities and Forecasts, 2015 -2022, projects that the ... 2022, registering a CAGR of 5.1% from 2015 to ... be the highest revenue-generating segment throughout the forecast period. ... one-third of the market share in 2015, and is ...
(Date:5/19/2016)... -- The equities market is never short of ... is without doubt the Healthcare space. ActiveWallSt.com has uncovered four ... Alkermes PLC (NASDAQ: ALKS ), AMAG Pharmaceuticals Inc. ... IDXX ), and Atossa Genetics Inc. (NASDAQ: ... http://www.activewallst.com/ On Wednesday, Alkermes PLC,s ...
(Date:5/19/2016)... 19, 2016 MGB Biopharma, ... of Anti-infectives, Welcomes the Final Instalment of Lord ... Today   Lord Jim O,Neill,s ... final recommendations, providing a comprehensive action plan for ... the rising threat of superbugs - something that ...
Breaking Medicine Technology: